|
|
|
MIRA
INFORM REPORT
|
Report No. : |
495053 |
|
Report Date : |
28.02.2018 |
|
|
|
IDENTIFICATION DETAILS
|
Name : |
USV PRIVATE LIMITED (w.e.f. 02.11.2015) |
|
|
|
|
Formerly Known
As : |
USV LIMITED (w.e.f. 13.05.1993) U. S. VITAMIN AND
PHARMACEUTICAL CORPORATION (INDIA) PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Arvind Vithal Gandhi Chowk, B S D Marg, Govandi, Mumbai – 400088, Maharashtra |
|
Tel. No.: |
91-22-25564048 / 67861111 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
25.08.1961 |
|
|
|
|
Com. Reg. No.: |
11-012098 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 978.910
Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239MH1961PTC012098 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
0388147407 |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACU1366N |
|
|
|
|
Legal Form : |
Private Limited Liability Company. |
|
|
|
|
Line of Business
: |
Subject is engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A++ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject was incorporated in the year 1961. It is engaged in manufacturing and selling of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics. For the financial year 2017, the company has achieved revenue growth of 11.45% as compared to the previous year along with a decent profit margin of 22.78%. The sound financial risk profile of the company is marked by adequate networth base along with strong debt coverage indicators due to debt free balance sheet profile. Rating takes into consideration the subject’s healthy Earnings Per
Share of INR 60.81 against the Face Value of INR 10. Rating takes into account the subject’s long established track record
of business operations along with extensive experience of its promoters. Payments seems to be regular. In view of aforesaid, the company can be considered good for business
dealings at usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term Bank Facilities= AA+ |
|
Rating Explanation |
High degree of safety and very low credit
risk. |
|
Date |
31.03.2017 |
|
Rating Agency Name |
CRISIL |
|
Rating |
Short Term Bank Facilities= A1+ |
|
Rating Explanation |
Very strong degree of safety and carry
lowest credit risk. |
|
Date |
31.03.2017 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 28.02.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED
Management Non-Cooperative (91-22-25564048)
LOCATIONS
|
Registered Office : |
Arvind Vithal Gandhi Chowk, B S D Marg, Govandi, Mumbai – 400088, Maharashtra, India |
|
Tel. No.: |
91-22-25564048 / 67861111 |
|
Fax No.: |
91-22-25584025 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
Locality : |
Commercial |
|
|
|
|
Factory : |
B-1/8, B-8, B-9, B-10, MIDC, Lote Parashuram, Ratnagiri – 415722,
Maharashtra, India |
|
|
|
|
Factories : |
Located at : · M.I.D.C. Lote Industrial Area, Khed, Ratnagiri, Maharashtra, India · Chiplun, Maharashtra, India · Nerul, New Mumbai, Maharashtra, India · OIDC, Dabhel, Daman, Daman and Diu, India · HPSIDC, Baddi, Himachal Pradesh, India · Hilltop Industrial Area, Jharmajri, Baddi, Himachal Pradesh, India |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Prashant Kumar Tewari |
|
Designation : |
Managing Director |
|
Address : |
41, Ritu Apartments, 208, B.J. Road, Bandra (West), Mumbai – 400050,
Maharashtra, India |
|
Date of Birth/Age : |
09.04.1958 |
|
Qualification : |
MS, B. Tech, IIT Kanpur |
|
Date of Appointment : |
01.05.2008 |
|
PAN No.: |
AAAPT6427C |
|
DIN No.: |
00001745 |
|
|
|
|
Name : |
Mrs. Leena Gandhi Tewari |
|
Designation : |
Director |
|
Address : |
41, Ritu Apartments, 208, B.J. Road, Bandra (West), Mumbai – 400050,
Maharashtra, India |
|
Date of Birth/Age : |
09.03.1957 |
|
Qualification : |
MBA, Boston University, USA, B. Com. |
|
Date of Appointment : |
20.01.1986 |
|
PAN No.: |
AAFPG5709D |
|
DIN No.: |
00001748 |
|
|
|
|
Name : |
Debabrata Bhadury |
|
Designation : |
Director |
|
Address : |
9A, Belvedere Court, Sane Guruji Marg, Mahalaxmi, Mumbai – 400011,
Maharashtra, India |
|
Date of Birth/Age : |
20.11.1941 |
|
Qualification : |
MA (Economics) |
|
Date of Appointment : |
01.05.2001 |
|
DIN No.: |
00001754 |
|
|
|
|
Name : |
Mr. Deepak Keshav Ghaisas |
|
Designation : |
Director |
|
Address : |
B/61-62, Swapnashilp, Mahant Road, Vile Parle (East), Mumbai – 400057,
Maharashtra, India |
|
Date of Birth/Age : |
19.11.1957 |
|
Qualification : |
CA, CS and ICWA |
|
Date of Appointment : |
23.08.2003 |
|
DIN No.: |
00001811 |
|
|
|
|
Name : |
Murugappan Muthiah Venkatachalam |
|
Designation : |
Director |
|
Address : |
20/1, Valliammai Achi Road, Kotturpuram, Chennai – 600085, Tamilnadu,
India |
|
Date of Birth/Age : |
24.11.1958 |
|
Qualification : |
MBA, Washington University, United States of America |
|
Date of Appointment : |
31.07.2007 |
|
DIN No.: |
00152619 |
|
|
|
|
Name : |
Jayant Dwivedy |
|
Designation : |
Wholetime Director |
|
Address : |
Flat No-703, 7th Floor, Octavius Hiranandani, Hiranandani Gardens,
Powai, Mumbai – 400076, Maharashtra, India |
|
Date of Appointment : |
11.07.2016 |
|
DIN No.: |
02833134 |
|
|
|
|
Name : |
Vilas Gandhi Tewari |
|
Designation : |
Director |
|
Address : |
5416, Fair Ave Apt 1321 N Hollywood CA 91601 USA |
|
Date of Appointment : |
27.09.2012 |
|
DIN No.: |
05354249 |
KEY EXECUTIVES
|
Name : |
Mr. Akhilesh Jain |
|
Designation : |
Company Secretary |
|
Address : |
Flat No.A-404, Plot No.23 A, Sector-6 Vihang Residency,
Nerul (West), Navi Mumbai – 400706, Maharashtra, India |
|
Date of Appointment : |
23.09.2017 |
|
PAN No.: |
AFXPJ9171R |
|
|
|
|
Name : |
Mr. Prakash Chandrasekharan Menon |
|
Designation : |
Chief Financial Officer |
|
Date of Appointment : |
18.06.2014 |
|
PAN No.: |
AACPM8929L |
|
|
|
|
Name : |
Mr. Halde |
|
Designation : |
Purchase Department |
|
|
|
|
Name : |
Mr. Vijay |
|
Designation : |
Accounts Department |
MAJOR SHAREHOLDERS
AS ON 31.03.2017
|
Names of Shareholders |
|
No. of Shares |
|
Leena Gandhi Tewari |
|
94715652 |
|
Prashant Kumar Tewari |
|
3175622 |
|
Vilas Gandhi Tewari |
|
6 |
|
Vilas Family Trust |
|
100 |
|
Aneesha Gandhi Tewari |
|
6 |
|
Aneesha Family Trust |
|
100 |
|
|
|
|
|
Total |
|
97891486 |
Equity Share Break up (Percentage of Total Equity)
AS ON 11.07.2017
|
Category |
Percentage |
|
Promoters [Individual/Hindu Undivided
Family (Indian)] |
99.99978343 |
|
Promoters [Individual/Hindu Undivided Family
(Foreign national {other than NRI})] |
0.00001226 |
|
Promoters [Others
(Two Family Trusts)] |
0.00020431 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics. [Registered Activity] |
||||||
|
|
|
||||||
|
Products / Services
: |
|
||||||
|
|
|
||||||
|
Brand Names : |
Not Available |
||||||
|
|
|
||||||
|
Agencies Held : |
Not Available |
||||||
|
|
|
||||||
|
Exports : |
Not Divulged |
||||||
|
|
|
||||||
|
Imports : |
Not Divulged |
||||||
|
|
|
||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information denied by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
Auditors : |
|
|
Name : |
B S R and Company LLP Chartered Accountants |
|
Address : |
301 C Wing, New Sarvottam CHS, L S V Road, Near Irla Bridge, Andheri (West), Mumbai – 400058, Maharashtra, India |
|
PAN No.: |
AAAFB9852F |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Subsidiary
companies : |
· Indicus Pharma LLC, United States · USV Europe Limited, United Kingdom · Bharavi Laboratories Private Limited, India · USV North America, Inc., United States · Aviat Health Care Private Limited, India ·
USV Labs Private Limited |
|
|
|
|
Enterprises which are owned, or have significant
influence of or are partners with Key management personnel and their
relatives : |
· V. B. Gandhi and Company, India · Treva Health Care Private Limited, India · Vipal Health Care Private Limited, India · USV Reliable Homes Private Limited, India · Neo Pharma Industries Private Limited, India · V-Kidd Computer Graphics Private Limited ·
Tender Management Consultants LLP |
CAPITAL STRUCTURE
AS ON 11.07.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
125000000 |
Equity Shares |
INR 10/- each |
INR 1250.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
97891486 |
Equity Shares |
INR 10/- each |
INR 978.915 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET (STANDALONE)
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
978.910 |
999.670 |
999.670 |
|
(b) Reserves and Surplus |
19425.670 |
17000.270 |
14890.970 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
20404.580 |
17999.940 |
15890.640 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
150.210 |
|
(c) Other long-term
liabilities |
717.910 |
829.670 |
0.000 |
|
(d) long-term
provisions |
486.070 |
443.210 |
57.230 |
|
Total Non-current
Liabilities (3) |
1203.980 |
1272.880 |
207.440 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade
payables |
2429.050 |
2236.340 |
1949.060 |
|
(c) Other
current liabilities |
965.790 |
971.200 |
561.160 |
|
(d) Short-term
provisions |
625.870 |
513.560 |
3586.630 |
|
Total Current
Liabilities (4) |
4020.710 |
3721.100 |
6096.850 |
|
|
|
|
|
|
TOTAL |
25629.270 |
22993.920 |
22194.930 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
3429.270 |
3208.740 |
3404.840 |
|
(ii)
Intangible Assets |
418.900 |
488.890 |
77.840 |
|
(iii) Tangible assets
capital work-in-progress |
1529.020 |
1412.610 |
423.330 |
|
(iv)
Intangible assets under development |
241.480 |
0.000 |
0.000 |
|
(b) Non-current Investments |
1718.480 |
2010.420 |
1407.050 |
|
(c) Deferred tax assets (net) |
1637.520 |
1732.210 |
0.000 |
|
(d)
Long-term
loans and advances |
146.980 |
97.830 |
1921.890 |
|
(e) Other
Non-current assets |
313.140 |
412.800 |
1.660 |
|
Total Non-Current
Assets |
9434.790 |
9363.500 |
7236.610 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
9506.450 |
7617.130 |
9791.290 |
|
(b)
Inventories |
2710.980 |
2280.380 |
1945.840 |
|
(c) Trade
receivables |
2051.150 |
2144.680 |
1883.710 |
|
(d) Cash and bank balances |
823.950 |
835.720 |
666.790 |
|
(e)
Short-term loans and advances |
201.780 |
111.190 |
663.610 |
|
(f) Other
current assets |
900.170 |
641.320 |
7.080 |
|
Total
Current Assets |
16194.480 |
13630.420 |
14958.320 |
|
|
|
|
|
|
TOTAL |
25629.270 |
22993.920 |
22194.930 |
PROFIT
& LOSS ACCOUNT (STANDALONE)
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Total
Revenue from operations |
26552.700 |
23825.180 |
20758.950 |
|
|
Other Income |
1195.830 |
1549.790 |
973.320 |
|
|
TOTAL |
27748.530 |
25374.970 |
21732.270 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
3441.290 |
3450.670 |
3591.270 |
|
|
Purchases of
Stock-in-Trade |
5084.010 |
4572.590 |
3708.170 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(361.780) |
(395.250) |
(70.640) |
|
|
Employee benefit expense |
2881.190 |
2479.070 |
2079.545 |
|
|
CSR expenditure |
81.940 |
34.810 |
45.200 |
|
|
Other expenses |
8082.810 |
7052.540 |
5737.845 |
|
|
TOTAL |
19209.460 |
17194.430 |
15091.390 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
8539.070 |
8180.540 |
6640.880 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
8539.070 |
8180.540 |
6640.880 |
|
|
|
|
|
|
|
Less |
DEPRECIATION/
AMORTISATION |
803.590 |
827.280 |
987.610 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
7735.480 |
7353.260 |
5653.270 |
|
|
|
|
|
|
|
Less |
TAX |
1686.060 |
1440.220 |
1218.990 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
6049.420 |
5913.040 |
4434.280 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
NA |
4433.000 |
3947.840 |
|
|
TOTAL EARNINGS |
NA |
4433.000 |
3947.840 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
NA |
1065.130 |
1008.410 |
|
|
Components and spare
parts |
NA |
195.590 |
105.840 |
|
|
Capital Goods |
NA |
552.620 |
164.920 |
|
|
TOTAL IMPORTS |
NA |
1813.340 |
1279.170 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
60.81 |
59.15 |
44.36 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
0.000 |
1.140 |
3.950 |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
7306.050 |
6645.330 |
5772.940 |
|
Net cash flows from (used in) operating activities |
5684.350 |
5043.150 |
4534.160 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
28.20 |
32.86 |
33.12 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
12.95 |
11.11 |
11.02 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
104.00 |
101.74 |
97.46 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
3.15 |
3.59 |
3.41 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
1.52 |
1.60 |
1.70 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.16 |
0.16 |
0.27 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.20 |
0.21 |
0.38 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.28 |
0.28 |
0.25 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
0.00 |
0.00 |
0.00 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
PAT to Sales ((PAT
/ Sales) * 100) |
% |
22.78 |
24.82 |
21.36 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
23.60 |
25.72 |
19.98 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
29.65 |
32.85 |
27.90 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
4.03 |
3.66 |
2.45 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
3.35 |
3.05 |
2.13 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.80 |
0.78 |
0.72 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
4.03 |
3.66 |
2.45 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
999.670 |
999.670 |
978.910 |
|
Reserves & Surplus |
14890.970 |
17000.270 |
19425.670 |
|
Net
worth |
15890.640 |
17999.940 |
20404.580 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
Current maturities of
long-term debts |
3.950 |
1.140 |
0.000 |
|
Total
borrowings |
3.950 |
1.140 |
0.000 |
|
Debt/Equity
ratio |
0.000 |
0.000 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
20758.950 |
23825.180 |
26552.700 |
|
|
|
14.771 |
11.448 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
20758.950 |
23825.180 |
26552.700 |
|
Profit/ (Loss) |
4434.280 |
5913.040 |
6049.420 |
|
|
21.36
% |
24.82
% |
22.78
% |
ABRIDGED
BALANCE SHEET (CONSOLIDATED)
|
SOURCES OF FUNDS |
|
31.03.2017 |
31.03.2016 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
978.910 |
999.670 |
|
(b) Reserves and Surplus |
|
19257.720 |
16622.610 |
|
(c) Money
received against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
|
10.520 |
11.460 |
|
Total
Shareholders’ Funds (1) + (2) |
|
20247.150 |
17633.740 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
|
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
|
0.000 |
0.000 |
|
(c) Other long-term
liabilities |
|
410.440 |
499.990 |
|
(d) long-term
provisions |
|
486.670 |
443.940 |
|
Total Non-current
Liabilities (3) |
|
897.110 |
943.930 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
|
0.000 |
0.000 |
|
(b) Trade
payables |
|
2422.820 |
2234.990 |
|
(c) Other
current liabilities |
|
1663.010 |
1516.900 |
|
(d) Short-term
provisions |
|
626.170 |
513.590 |
|
Total Current
Liabilities (4) |
|
4712.000 |
4265.480 |
|
|
|
|
|
|
TOTAL |
|
25856.260 |
22843.150 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
|
3450.510 |
3236.600 |
|
(ii)
Intangible Assets |
|
425.400 |
495.390 |
|
(iii) Tangible assets
capital work-in-progress |
|
1529.020 |
1412.610 |
|
(iv)
Intangible assets under development |
|
241.480 |
0.000 |
|
(b) Non-current Investments |
|
1671.550 |
1997.360 |
|
(c) Deferred tax assets (net) |
|
1221.070 |
1254.500 |
|
(d)
Long-term
loans and advances |
|
148.790 |
99.620 |
|
(e) Other
Non-current assets |
|
454.080 |
426.330 |
|
Total Non-Current
Assets |
|
9141.900 |
8922.410 |
|
|
|
|
|
|
(2) Current
assets |
|
|
|
|
(a)
Current investments |
|
9506.450 |
7617.130 |
|
(b)
Inventories |
|
2716.650 |
2285.910 |
|
(c) Trade
receivables |
|
2132.290 |
2212.110 |
|
(d) Cash and bank
balances |
|
1473.210 |
1114.800 |
|
(e)
Short-term loans and advances |
|
126.610 |
48.900 |
|
(f) Other
current assets |
|
759.150 |
641.890 |
|
Total
Current Assets |
|
16714.360 |
13920.740 |
|
|
|
|
|
|
TOTAL |
|
25856.260 |
22843.150 |
PROFIT
& LOSS ACCOUNT (CONSOLIDATED)
|
|
|
|
31.03.2017
31.03.2016